Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension
Current Medical Research and Opinion (2011) - Comments
pubmed: 21241207  doi: 10.1185/03007995.2010.547575  issn: 1473-4877  issn: 0300-7995 

Jeffrey Hyams, Thomas D. Walters, Wallace Crandall, Subra Kugathasan, Anne Griffiths, Marion Blank, Jewel Johanns, Yinghua Lang, James Markowitz, Stanley Cohen, Harland S. Winter, Gigi Veereman-Wauters, George Ferry, Robert Baldassano